![]() |
| |
| |
TIME
Daily April 22, 1998
We should have seen
this coming from a mile away. Any country that found in Prozac an excuse to dope
itself to the gills over the occasional bad hair day was bound to go nuts over a
drug that promised -- and delivered! -- the sexual Holy Grail: Dependable
erections. Any-time, no-questions-asked hard-ons courtesy of a little
diamond-shaped pill retailing for $7-10 each.
Two weeks into the release of
Pfizer's new impotence drug Viagra, the numbers are impressive to say the least.
An estimated 40,000 impotence prescriptions are filled each day. Viagra suddenly
controls 79 percent of the impotence drug market, according to drug research firm
IMS America. And then there's the anecdotal evidence: One doctor has stopped
taking calls. Another now uses a rubber stamp to fill prescriptions because he
says his hand's getting cramped. Newspapers were giddy: "Doctors Can Barely Keep
Up As Men Flock For Love Drug," gushed the
New York Post, while Reuters
shamelessly added that "Drug Analyst Says Viagra Sales Appear Enormous." All this
before Pfizer has even had a chance to unleash an advertising campaign.
Comparisons were immediately made to Prozac. . .
(continued)
|